Cargando…

All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma

PURPOSE: Peripheral T-cell lymphoma (PTCL) is a rare and heterogenous hematologic malignancy with poor prognosis especially in elderly and frail patients who are not eligible for intensive treatment. The resulting palliative setting necessitates tolerable but effective schedules for outpatient treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fante, Matthias A., Harrer, Dennis C., Zartner, Barbara, Lüke, Florian, Mayer, Stephanie, Menhart, Karin, Reichle, Albrecht, Herr, Wolfgang, Vogelhuber, Martin, Heudobler, Daniel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10250661/ https://www.ncbi.nlm.nih.gov/pubmed/37305564 http://dx.doi.org/10.3389/fonc.2023.1177330

Ejemplares similares

All-Oral Low-Dose Chemotherapy TEPIP is Effective and Well-Tolerated in Relapsed/Refractory Patients With Aggressive B-Cell Lymphoma
por: Fante, Matthias A., et al.
Publicado: (2022)

Unusual Late Relapse of ALK-Positive Anaplastic Large Cell Lymphoma Successfully Cleared Using the ALK-Inhibitor Crizotinib: Case Report
por: Harrer, Dennis Christoph, et al.
Publicado: (2020)

Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin’s Disease
por: Lüke, Florian, et al.
Publicado: (2021)

Case Report: Extramedullary Acute Promyelocytic Leukemia: An Unusual Case and Mini-Review of the Literature
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

Gemcitabine Maintenance Therapy in Patients With Metastasized Soft Tissue Sarcomas
por: Harrer, Dennis Christoph, et al.
Publicado: (2021)

Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy
por: Lüke, Florian, et al.
Publicado: (2021)

Peroxisome Proliferator-Activated Receptors (PPAR)γ Agonists as Master Modulators of Tumor Tissue
por: Heudobler, Daniel, et al.
Publicado: (2018)

Low-dose trofosfamide plus rituximab is an effective and safe treatment for diffuse large B-cell lymphoma of the elderly: a single center experience
por: Schelker, Roland Christian, et al.
Publicado: (2018)

Anakoinosis: Correcting Aberrant Homeostasis of Cancer Tissue—Going Beyond Apoptosis Induction
por: Heudobler, Daniel, et al.
Publicado: (2019)

Case Report: Dual Checkpoint Inhibition in Advanced Metastatic Osteosarcoma Results in Remission of All Tumor Manifestations—A Report of a Stunning Success in a 37-Year-Old Patient
por: Sterz, Ulrich, et al.
Publicado: (2021)

Drug Repurposing by Tumor Tissue Editing
por: Lüke, Florian, et al.
Publicado: (2022)

Clinical Efficacy of a Novel Therapeutic Principle, Anakoinosis
por: Heudobler, Daniel, et al.
Publicado: (2018)

Biomodulatory metronomic therapy in stage IV melanoma is well‐tolerated and may induce prolonged progression‐free survival, a phase I trial
por: Hart, C., et al.
Publicado: (2015)

Cutaneous Leukemic Infiltrates Successfully Treated With Biomodulatory Therapy in a Rare Case of Therapy-Related High Risk MDS/AML
por: Heudobler, Daniel, et al.
Publicado: (2018)

Editorial: Anakoinosis: An Innovative Anticancer Therapy Targeting the Aberrant Cancer Tissue Homeostasis
por: Heudobler, Daniel, et al.
Publicado: (2021)

Editorial: Anakoinosis for promoting tumor tissue editing: Novel therapeutic opportunities for establishing clinically relevant tumor control by targeting tumor plasticity
por: Heudobler, Daniel, et al.
Publicado: (2022)

Successful Treatment of Early Relapsed High-Risk AML After Allogeneic Hematopoietic Stem Cell Transplantation With Biomodulatory Therapy
por: Kattner, Anna-Sophia, et al.
Publicado: (2020)

Unusually swift response of relapsed Burkitt leukemia to R‐DHAP
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

A Randomized Phase II Trial Comparing the Efficacy and Safety of Pioglitazone, Clarithromycin and Metronomic Low-Dose Chemotherapy with Single-Agent Nivolumab Therapy in Patients with Advanced Non-small Cell Lung Cancer Treated in Second or Further Line (ModuLung)
por: Heudobler, Daniel, et al.
Publicado: (2021)

Coronavirus disease 2019 induces multi‐lineage, morphologic changes in peripheral blood cells
por: Lüke, Florian, et al.
Publicado: (2020)

Anakoinosis: Communicative Reprogramming of Tumor Systems - for Rescuing from Chemorefractory Neoplasia
por: Hart, Christina, et al.
Publicado: (2015)

Editorial: Tumor Systems Biology: How to Therapeutically Redirect Dysregulated Homeostasis in Tumor Systems (i.e., Anakoinosis)
por: Reichle, Albrecht, et al.
Publicado: (2020)

Biomodulatory Treatment With Azacitidine, All-trans Retinoic Acid and Pioglitazone Induces Differentiation of Primary AML Blasts Into Neutrophil Like Cells Capable of ROS Production and Phagocytosis
por: Klobuch, Sebastian, et al.
Publicado: (2018)

Communicative reprogramming non-curative hepatocellular carcinoma with low-dose metronomic chemotherapy, COX-2 inhibitor and PPAR-gamma agonist: a phase II trial
por: Walter, I., et al.
Publicado: (2017)

Rapid infusion rituximab is well tolerated in patients with primary CNS lymphoma
por: Modelevsky, Lisa, et al.
Publicado: (2018)

All's well that ends well /
por: Shakespeare, William, 1564-1616
Publicado: (1986)

All-oral metronomic DEVEC schedule in elderly patients with peripheral T cell lymphoma
por: Cox, Maria Christina, et al.
Publicado: (2020)

Systems Biology: A Therapeutic Target for Tumor Therapy
por: Reichle, Albrecht, et al.
Publicado: (2008)

Association of ST-T changes with all-cause mortality among patients with peripheral T-cell lymphomas
por: Du, Hanzhi, et al.
Publicado: (2022)

Principles of Modular Tumor Therapy
por: Reichle, Albrecht, et al.
Publicado: (2009)

Attention is not all you need: the complicated case of ethically using large language models in healthcare and medicine
por: Harrer, Stefan
Publicado: (2023)

Differentiated Thyroid Cancer—Treatment: State of the Art
por: Schmidbauer, Benedikt, et al.
Publicado: (2017)

IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

A Computational Model of Tumor Growth and Anakoinosis
por: Pantziarka, Pan, et al.
Publicado: (2019)

“All is Not Well” with Medical Tourism
por: Garg, Rajesh
Publicado: (2013)

All over and Doing Well
por: Raymond, Mary Corner
Publicado: (1915)

Response to M. Trengove & coll regarding “Attention is not all you need: the complicated case of ethically using large language models in healthcare and medicine”
por: Harrer, Stefan
Publicado: (2023)

Biomodulatory Treatment of Patients with Castration-Resistant Prostate Cancer: A Phase II Study of Imatinib with Pioglitazone, Etoricoxib, Dexamethasone and Low-Dose Treosulfan
por: Vogelhuber, M., et al.
Publicado: (2014)

Peripheral T cell lymphoma
por: Patel, Moosa
Publicado: (2018)

Othello King Lear, all 's well that ends well, Macbeth /
por: Shakespeare, William, 1564-1616
Publicado: (1912)

Cannot write session to /tmp/vufind_sessions/sess_ip9s6q1hsthc2alvlnabesh690